uniQure N.V. Banner Image

uniQure N.V. has reached its limit for free report views

Work for uniQure N.V.? Upgrade Your Profile and unlock all your annual reports.

uniQure N.V.

  • Ticker QURE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
uniQure N.V. Logo Image
  • 201-500 Employees
  • Based in Amsterdam, Netherlands
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. They are leveraging their modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with hemophilia B, Huntington's disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases.
4.8 / 5.0 (122)

uniQure N.V. reports have an aggregate usefulness score of 4.8 based on 122 reviews.

uniQure N.V.

Most Recent Annual Report

uniQure N.V.
MOST RECENT 2021 Annual Report and Form 10K

Report Locked. uniQure N.V. has reached its limit for free report views.

Older/Archived Annual Reports

uniQure N.V. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!